Month: July 2024

Manufacturers provide long-term data on rejected...

Manufacturers provide long-term data on rejected…

31 July, 2024 doctor 0 Comments 1 category

medicine Wednesday, July 31, 2024 Tokyo/Cambridge – The beneficial effects of the antibody lecanemab, which is approved in the USA, Japan, China, South Korea and Israel, but not in Europe, for the treatment of early

Read More
Semaglutide could also help with smoking cessation

Semaglutide could also help with smoking cessation

31 July, 2024 doctor 0 Comments 1 category

medicine Wednesday, July 31, 2024 Cleveland/Ohio – Can GLP 1 agonists help smokers give up cigarettes? An analysis of electronic medical records in the Annals of Internal Medicine (2024; DOI: 10.7326/M23-2718) shows that patients who

Read More
German Society for Internal Medicine (Wiesbaden): Secretary

German Society for Internal Medicine (Wiesbaden): Secretary

31 July, 2024 doctor 0 Comments 1 category

With around 30,000 members, the German Society for Internal Medicine (DGIM) is today the largest medical-scientific professional society in Europe. Founded in Wiesbaden in 1882, the DGIM unites the interests of scientists and doctors working

Read More
EMA examines agranulocytosis risk of metamizole

EMA examines agranulocytosis risk of metamizole

31 July, 2024 doctor 0 Comments 1 category

medicine Tuesday, July 30, 2024 Amsterdam The European Medicines Agency (EMA) is reviewing the safety of drugs that contain the painkiller metamizole (Novaminsulfon). There are fears that the existing measures to reduce the risk of

Read More
No extension of indication for semaglutide, but label update

No extension of indication for semaglutide, but label update

31 July, 2024 doctor 0 Comments 1 category

medicine Tuesday, July 30, 2024 Brussels The European Medicines Agency (EMA) has spoken out against an extension of the indication for semaglutide to prevent cardiovascular events, but recommends including additional information in the product information.

Read More